The global bone morphogenetic proteins market is likely to gain momentum from a rise in the prevalence of traumatic injuries. Fortune Business Insights, in an upcoming report, titled, “Bone Morphogenetic Proteins Market Size, Share and Global Trend By Type (rhBMP-2, rhBMP-7, Others), By Application (Spinal Fusion, Trauma Surgery, Reconstructive Surgery, Maxillofacial & Dental), and Geography Forecast till 2026,” states that increasing number of spinal fusion procedures and a rise in the investments by prominent market players in the research and development are anticipated to boost the global market growth during the forecast period.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/bone-morphogenetic-proteins-market-100346
List of Companies mentioned in the Global Bone Morphogenetic Proteins Market Research Report:
- Cellumed Co. Ltd.
- Sigma-Aldrich Co.
- ProSpec-Tany TechnoGene Ltd.
- Ember Therapeutics
- DePuy Synthes
- Other key market players
Segmentation of the Global Bone Morphogenetic Proteins Market
- Spinal Fusion
- Trauma Surgery
- Reconstructive Surgery
- Maxillofacial & Dental
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Request a Sample Copy of the Global Bone Morphogenetic Proteins Market Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/bone-morphogenetic-proteins-market-100346
Medtronic Receives FDA Approval for Clinical trial to Study Infuse Bone Graft in TLIF Spine Procedures
Medtronic, a medical device company, headquartered in Ireland, declared that it has received FDA approval for pivotal, randomized, and prospective clinical trials for the use of Infuse bone graft in September 2019. The study will allow the usage of bone graft for Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures. TLIF is a type of surgery that joins or fuses spinal bones by a posterior approach. It allows to treat few of the painful conditions of the lower back region of the spine. The company started site recruitment for the clinical trial of TLIF to register almost 50 sites with over 1,000 patients.
KEY QUESTIONS ANSWERED:
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
More Trending Topics From Fortune Business [email protected]